Place of vitamin D in the prevention of premature aging and the development of age-associated diseases


Cite item

Full Text

Abstract

There is an ongoing search for the molecular and biochemical mechanisms underlying the development of aging and age-associated diseases. At the same time there is growing evidence geroprotective properties of vitamin D.In this review, described in detail the possible mechanisms by which vitamin D affects differentiation, cell proliferation and apoptosis, and describes the potential benefits of this vitamin in the fight against aging and age-related diseases.

About the authors

O M Drapkina

Federal State Institution "National Research Center for Preventive Medicine" of the Ministry of Healthcare of the Russian Federation; Sechenov First Moscow State Medical University

член-корр. РАН, д.м.н., проф., зам. директора по научной и лечебной работе ФГБУ «Государственный научно-исследовательский центр профилактической медицины» Минздрава России; проф. каф. факультетской терапии №1 ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

R N Shepel

Federal State Institution "National Research Center for Preventive Medicine" of the Ministry of Healthcare of the Russian Federation

Email: r.n.shepel@mail.ru
м.н.с. отдела функциональных и прикладных аспектов ожирения ФГБУ «Государственный научно-исследовательский центр профилактической медицины» Минздрава России

V V Fomin

Sechenov First Moscow State Medical University

член-корр. РАН, д.м.н., проф., зав. каф. факультетской терапии №1 ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

A A Svistunov

Sechenov First Moscow State Medical University

член-корр. РАН, д.м.н., проф., первый проректор ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

References

  1. Holick M, Mac Laughlin J, Clark M, Holick S. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 2010;210:203-205. doi: 10.1126/science.6251551
  2. The norms physiological needs for energy and nutrients for different groups of the population of the Russian Federation. Metodicheskie rekomendatsii. MR 2.3.1.2432 - 08 (18.12.2008) 41 р. Russian (Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. Методические рекомендации. МР 2.3.1.2432 - 08 (от 18 декабря 2008 г.) 41 с.)
  3. National Institute of Health. Dietary supplement fact sheet: vitamin D. Доступно по: http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ Ссылка активна на 15.04.2016 г.
  4. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81: 353-373. doi: 10.4065/81.3.353
  5. Федеральные клинические рекомендации "Дефицит витамина D у взрослых: диагностика, лечение и профилактика". 2015 г. 15 октября 2015 г. Доступно по: http://www.endocrincentr.ru/science/public/ consenss/932/ Ссылка активна на 15.04.2016 г.
  6. Webb A.R, Kline L, Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988; 67: 373-378. doi: 10.1210/jcem-67-2- 373
  7. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2010.
  8. Pappa H.M, Bern E, Kamin D, Grand R.J. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol. 2008;24:176-183. doi: 10.1097/MOG.0b013e3282f4d2f3
  9. Lai L, Lucas R, Clements M, Roddam A, Banks E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta - analysis of randomised controlled trials and observational studies. J Clin Invest. 1990; 85: 1296-1303. PMID: 20540727
  10. van der Mei I.A, Ponsonby A.L, Dwyer T. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case - control study. BMJ. 2003;327:316. doi: 10.1136/bmj.327.7410.316
  11. Ginde A, Mansbach K, Camargo C.J. Association between serum 25-hydroxyvitamin D level and upper respiratory trct infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009; 169: 384-390. doi: 10/1001/archinternmed.208.560
  12. Nnoaham K, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta - analysis. Int J Epidemiol. 2008; 37: 113-119. doi: 10.1093/ije/dym247
  13. Pittas A, Lau J, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. J Clin Endocrinol Metab. 2007; 92: 2017-2019. doi: https://doi.org/10.1210/jc.2007-0298
  14. Kim D.H, Sabour S, Sagar U.N, Adams S, Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008; 102: 1540-1544. doi: 10.1016/j.amjcard.2008.06.067
  15. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd M.J, et al. Meta - analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011; 128: 1414-1424 . doi: 10.1002/ijc.25439
  16. Cherniack E, Troen B, Florenz H, Roos B, Levis S. Some new food for thought: the role of vitamin D in the mental health of older adults. Curr Psychiatry Rep. 2009; 11: 12-19. PMID: 19187703
  17. Salahuddin N, Ali F, Hasan Z, Rao N, Ageel M, Mahmood F. Vitamin D accelerates clinical recovery from tubercolosis: results of the SUCCINCT. A randomized placebo - controlled, clinical trial of vitamin D supplementation in patients with pulmonary tubercolosis. BMC Infect Dis. 2013; 13: 22. doi: 10.1186/1471-2334-13-22
  18. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation of symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008; 264: 599-609. doi: 10.1111/j.1365-2796.2008.02008.x
  19. Grath J, Saari K, Hakko H. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth - cohort study. Schizophr Res. 2004; 67: 237-245. doi: 10.1016/j.schres.2003.08.005
  20. Myhr K. Vitamin D treatment in multiple sclerosis. J Neurol Sci. 2009; 286: 104-108. DOI: http://dx.doi.org/10.1016/j.jns.2009.05.002
  21. Gloth F.M, III, Gundberg C.M, Hollis B.W, Haddad J.G. Jr., Tobin J.D. Vitamin D deficiency in homebound elderly persons. JAMA. 1995; 274: 1683-1686. doi: 10.1001/jama.1995.03530210037027
  22. Deeb K.K, Trump D.L, Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7: 684-700. doi: :10.1038/nrc2196
  23. Ylikomi T, Laaksi I, Lou Y.R, Martikainen P, Miettinen S, Pennanen P, et al. Antiproliferative action of vitamin D. Vitam Horm. 2002; 64: 357-406. PMID: 11898396
  24. Nakagawa K., Yamamura K., Maeda S, et al. Bcl-2 expression in epidermal keratinocytic diseases. Cancer. 1994; 74: 1720-1724. doi: 10.1002/1097-0142(19940915)74:6<1720:AID- CNCR2820740613 >3.0.CO;2-T
  25. Lanske B, Razzaque M.S. Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr Opin Nephrol Hypertens. 2007; 16: 311-318. doi: 10.1097/MNH.0b013e3281c55eca
  26. Sitara D, Razzaque M.S, Hesse M, et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex - deficient mice. Matrix Biology. 2004; 23 (7): 421-432. doi: 10.1016/j.matbio.2004.09.007
  27. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. Journal of Clinical Investigation. 2004; 113 (4): 561-568. doi: 10.1172/JCI19081
  28. Kuroo M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390: 45-51. doi: 10.1038/36285
  29. Kuroo M. Klotho as a regulator of oxidative stress and senescence. Biol Chem. 2008; 389: 233-241. doi: 10.1515/BC.2008.028
  30. Lie D.C, Colamarino S.A, Song H.J, Désiré L, Mira H, Consiglio A, Lein E.S, Jessberger S, Lansford H, Dearie A.R, Gage F.H (October 2005). «Wnt signalling regulates adult hippocampal neurogenesis». Nature. 437 (7063): 1370-1375. doi: 10.1038/nature04108
  31. Drapkina O.M, Shepel R.N. Omega-3 polyunsaturated fatty acids and age - related diseases: reality and prospects. Ratsional'naya farmakoterapiya v kardiologii. 2015; 11(3): 309-316. Russian (Драпкина О.М., Шепель Р.Н. Омега-3 полиненасыщенные жирные кислоты и возраст - ассоциированные болезни: реалии и перспективы. Рациональная фармакотерапия в кардиологии. 2015; 11(3): 309-316.) doi: http://dx.doi.org/10.20996/1819-6446-2015-11-3-309-316
  32. Drapkina O.M, Shepel R.N. Telomere length and cardiovascular diseases: focus on chronic psychological stress. Kardiologiya: novosti, mneniya, obuchenie. 2015; 2: 48-53. Russian (Драпкина О.М., Шепель Р.Н. Длина теломер и сердечно - сосудистые заболевания: акцент на хронический психологический стресс. Кардиология: новости, мнения, обучение. 2015; 2: 48-53.)
  33. Drapkina O.M., Shepel R.N. Sleep duration: modern view of the problem from the standpoint of a cardiologist. Ratsional'naya farmakoterapiya v kardiologii. 2015; 11(4): 413-419. (Драпкина О.М., Шепель Р.Н. Продолжительность сна: современный взгляд на проблему с позиций кардиолога. Рациональная фармакотерапия в кардиологии. 2015; 11(4): 413-419.) doi: http://dx.doi.org/10.20996/1819-6446-2015-11-4-413-419
  34. Drapkina O.M, Shepel R.N. The modern conception of the proper role of telomeres and telomerase in pathogenesis of hypertension. Arterial'naya gipertenziya. 2013; 19(4): 290-298. (Драпкина О.М., Шепель Р.Н. Современные представления о роли теломер и теломеразы в патогенезе гипертонической болезни. Артериальная гипертензия. 2013; 19(4): 290-298.)
  35. Drapkina O.M, Shepel R.N. Telomeres and chronic heart failure. Kardiologiya. 2014; 54(4): 60-67 Russian (Драпкина О.М., Шепель Р.Н. Теломеры и хроническая сердечная недостаточность. Кардиология. 2014; 54(4): 60-67.) doi: http://dx.doi.org/10.18565/cardio.2015.10.85-89
  36. Cappuccio F.P, D’Elia L, Strazzullo P, Miller M.A Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta - analysis. Diabetes Care. 2010; 33: 414-420. doi: 10.2337/dc09-1124
  37. Cappuccio F.P, Taggart F.M, Kandala N.B, Currie A, Peile E, Stranges S, Miller M.A. Meta - analysis of short sleep duration and obesity in children, adolescents and adults. Sleep. 2008; 31: 619-626. PMCID: PMC2398753
  38. Ikehara S, Iso H, Date C, Kikuchi S, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009; 32(3): 259-301. PMCID: PMC2647783
  39. Lemire J.M. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992; 49: 26-31. doi: 10.1002/jcb.240490106
  40. Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998; 62: 193-198. PMID: 9501950
  41. Deluca H.F, Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001; 15: 2579-2585. doi: 10.1096/fj.01-0433rev
  42. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002;8:174-179. doi: http://dx.doi.org/10.1016/S1471-4914(02)02294-3
  43. Richards J.B, Valdes A.M, Gardner J.P, Paximadas D, Kimura M, Nessa A, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr. 2007; 86: 1420-1425. PMCID: PMC2196219
  44. Liu J.J, Prescott J, Giovannucci E, Hankinson S.E, Rosner B, Han J, et al. Plasma vitamin D biomarkers and leukocyte telomere length. Am J Epidemiol. 2013; 177: 1411-1417. doi: 10.1093/aje/kws435
  45. Kamen D.L, Aranow C (2008) The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 10: 273-280. PMID: 18662506
  46. Hoffecker B.M, Raffield L.M, Kamen D.L, Nowling T.K. Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: a case - control study. PLoS One. 2013; 8:e63725. doi: 10.1371/journal.pone.0063725
  47. Valdes A.M, Andrew T, Gardner J.P, Kimura M, Oelsner E, Cherkas L.F, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366: 662-664.
  48. Gardner J.P, Li S, Srinivasan S.R, Chen W, Kimura M, Lu X, et al. Rise in insulin resistance is associated with escalated telomere asttrition. Circulation. 2005; 111: 2171-2177. doi: 10.1161/01.CIR.0000163550. 70487.0B
  49. Kim S, Parks C.G, De Roo L.A, Chen H, Taylor J.A, Cawthon R.M, et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev. 2009; 18: 816-820. doi: 10.1158/1055-9965.EPI-08-0935
  50. Lee M, Martin H, Firpo A, Demerath E.W. Inverse association between adiposity and telomere length: The Fels Longitudinal Study. Am J Hum Biol. 2011; 23: 100-106. doi: 10.1002/ajhb.21109
  51. Drapkina O.M, Shepel R.N. Telomeres and telomerase complex. The main manifestations of the genetic fault. Kardiovaskulyarnaya Terapiya i Profilaktika. 2015; 1: 70-77. Russian (Драпкина О.М., Шепель Р.Н. Теломеры и теломеразный комплекс. Основные проявления генетического сбоя. Кардиоваскулярная Терапия и Профилактика. 2015; 1: 70-77.). doi: http://dx.doi.org/10.15829/1728-8800-2015-1-70-77
  52. Perez-Rivero G, Ruiz-Torres M.P, Rivas-Elena J.V, Jerkic M, Diez-Marques M.L, Lopez-Novoa J.M, et al. Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production. Circulation. 2006; 114: 309-317. doi: 10.1161/CIRCULATIONAHA.105.611111
  53. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens. 2005; 23: 1831-1837. PMID: 16148606
  54. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003; 22: 131-139. doi: 10.1093/emboj/cdg013
  55. Franco S, Segura I, Riese H.H, Blasco M.A. Decreased B16F10 melanoma growth and impaired vascularization in telomerase - deficient mice with critically short telomeres. Cancer Res. 2002; 62: 552-559.
  56. Zhu H, Guo D, Li K, Pedersen-White J, Stallmann-Jorgensen I.S, Huang Y, et al. Increased telomerase activity and vitamin D supplementation in overweight African Americans. Int J Obes (Lond). 2012; 36: 805- 809. doi: 10.1038/ijo.2011.197
  57. Bikbov B.T, Tomilina N.A. Status replacement therapy in patients with chronic renal failure in the Russian Federation in 1998-2009 years. Report to the Russian Register of renal replacement. Nefrologiya i dializ. 2014; 16(1): 11-127. Russian (Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2009 гг. Отчет по данным Российского регистра заместительной почечной терапии. Нефрология и диализ. 2014; 16(1): 11-127.)
  58. Ramirez R, Carracedo J, Soriano S, et al. Stress - induced premature senescence in mononuclear cells from patients on long - term hemodialysis. Am J Kidney Dis. 2005; 45: 353- 359. PMID: 15685514
  59. Borras M, Panizo S, Sarro F, Valdivielso J.M, Fernandez E. Assessment of the potential role of active vitamin D treatment in telomere length: a case - control study in hemodialysis patients. Clin Ther. 2012;34:849-856. doi: http://dx.doi.org/10.1016/j.clinthera.2012.02.016
  60. Finkel T, Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408: 239-247. doi: 10.1038/35041687
  61. Valdes A.M, Andrew T, Gardner J.P, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366: 662-664. doi: 10.1016/S0140-6736(05)66630-5
  62. Nawrot T.S, Staessen J.A, Gardner J.P, Aviv A. Telomere length and possible link to X chromosome. Lancet. 2004; 363: 507-510. doi: 10.1016/S0140-6736(04)15535-9
  63. Drapkina O.M, Shepel R.N. Physical inactivity is a disease of the century: physical inactivity as risk factor for diseases of the cardiovascular system and premature aging. Kardiologiya: novosti, mneniya, obuchenie. 2015; 3: 53-58. Russian (Драпкина О.М., Шепель Р.Н. Гиподинамия - болезнь века: низкая физическая активность как фактор риска заболеваний сердечно - сосудистой системы и преждевременного старения. Кардиология: новости, мнения, обучение. 2015; 3: 53-58.)

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies